Pre-implantation genetic diagnosis is the genetic profiling of embryos prior to implantation, and sometimes even of oocytes prior to fertilization. PGD is considered in a similar fashion to prenatal diagnosis

Get Sample Copy of This Report @ https://www.orianresearch.com/request-sample/1374539

The global preimplantation genetic testing market was estimated to be valued at USD XX million in 2019 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2020 to 2026. Rising number of fertility clinics worldwide market are the factors supporting the market growth globally. However, high procedural cost associated with preimplantation genetic testing is expected to hamper the growth of the global market.

The global preimplantation genetic testing market is segmented based on procedure type, technology, and region. Based on procedure type, it is divided into preimplantation genetic screening, preimplantation genetic diagnosis. Based on technology, it is categorized next-generation sequencing, polymerase chain reaction, fluorescence in situ hybridization, comparative genomic hybridization, single-nucleotide polymorphism. Region wise, it is analyzed across North America, Europe, Asia-Pacific, South America, and MEA.

On the basis of procedure type, the market is split into:* Preimplantation Genetic Screening* Preimplantation Genetic Diagnosis

Order Copy of this Report 2020 @ https://www.orianresearch.com/checkout/1374539

On the basis of technology, the market is split into:* Next-Generation Sequencing* Polymerase Chain Reaction* Fluorescence in Situ Hybridization* Comparative Genomic Hybridization* Single-Nucleotide Polymorphism

Moreover, the market is classified based on regions and countries as follows:* North America- U.S., Canada* Europe- U.K., France, Germany, Italy and Rest of Europe* Asia-Pacific- China, Japan, India and Rest of Asia Pacific* South America- Brazil, Mexico and Rest of South America* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:The key players profiled in the market include:* Illumina, Inc.* Thermo Fisher Scientific Inc.* Agilent Technologies, Inc.* Perkinelmer, Inc.* Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)* ABBott Laboratories* Natera, Inc.* Rubicon Genomics (A Subsidiary of Takara Bio USA Holdings, Inc.)* Oxford Gene Technology* Yikon Genomics

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:* Global, regional, country, procedure type, technology and market size and their forecast from 2015-2026* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points* Analysis on key players strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors short term and long term strategies* Detailed insights on emerging regions procedure type, technology, with qualitative and quantitative information and facts

Inquire more or share a question if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/1374539

Target Audience:* Preimplantation Genetic Testing Device Manufacturers* Traders, Importers, and Exporters* Raw Material Suppliers and Distributors* Research and Consulting Firms* Government and Research Organizations* Associations and Industry Bodies

Research Methodology:The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:* Manufacturers* Suppliers* Distributors* Government Body & Associations* Research InstitutesAbout UsOrian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.Contact Us:Ruwin MendezVice President Global Sales & Partner RelationsOrian Research ConsultantsUS: +1 (415) 830-3727 | UK: +44 020 8144-71-27Email: [emailprotected]

See the article here:
Global Preimplantation Genetic Testing Market Size, by Procedure Type (Preimplantation Genetic Screening), by Technology (Next-Generation Sequencing,...

Comments are closed.